SCHEDULE 13G

Company

Karyopharm Therapeutics Inc.

Filed

February 27, 2019

Accession Number

0000899140-19-000266

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →